Bio-electrode composition, bio-electrode, and method for manufacturing bio-electrode

Patent metadata

Field	Value
Publication number	US-11643492-B2
Application number	US-202016815315-A
Country	US
Kind code	B2
Filing date	Mar 11, 2020
Priority date	Apr 3, 2019
Publication date	May 9, 2023
Grant date	May 9, 2023

Abstract

A bio-electrode composition includes (A) an ionic material and (B) a lithium titanate powder. The component (A) is a polymer compound containing a repeating unit-a having a structure selected from an ammonium salt, a sodium salt, a potassium salt, and a silver salt of any of fluorosulfonic acid, fluorosulfonimide, and N-carbonyl-fluorosulfonamide. Thus, the present invention provides a bio-electrode composition capable of forming a living body contact layer for a bio-electrode that is excellent in electric conductivity and biocompatibility, is light-weight, can be manufactured at low cost, and can control significant reduction in the electric conductivity even when the bio-electrode is wetted with water or dried; a bio-electrode including a living body contact layer formed of the bio-electrode composition; and a method for manufacturing the bio-electrode.

First claim

The invention claimed is:

1. A bio-electrode composition comprising:
(A) an ionic material; and
(B) a lithium titanate powder, wherein the component (A) is a polymer compound comprising a repeating unit-a having at least one structure selected from the group consisting of the following general formulae (1)-1 to (1)-4,

wherein Rf 1 and Rf 2 each represent a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group, provided that when Rf 1 represents an oxygen atom, Rf 2 represents the oxygen atom to form a carbonyl group together with a carbon atom bonded therewith; Rf 3 and Rf 4 each represent a hydrogen atom, a fluorine atom, or a trifluoromethyl group, provided that at least one of Rf 1 to Rf 4 is a fluorine atom or a trifluoromethyl group; Rf 5 , Rf 6 , and Rf 7 each represent a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms and at least one or more fluorine atoms; m represents an integer of 1 to 4; and M + represents an ion selected from the group consisting of an ammonium ion, a sodium ion, a potassium ion, and a silver ion.

2. The bio-electrode composition according to claim 1 , wherein the repeating unit-a is at least one repeating unit selected from the group consisting of repeating units-a1 to -a7 shown by the following general formula (2),

wherein R 1 , R 3 , R 5 , R 8 , R 10 , R 11 and R 13 each independently represent a hydrogen atom or a methyl group; R 2 , R 4 , R 6 , R 9 , and R 12 each independently represent any of a single bond, an ester group, and a linear, branched, or cyclic hydrocarbon group having 1 to 13 carbon atoms optionally having either or both of an ether group and an ester group; R 7 represents a linear or branched alkylene group having 1 to 4 carbon atoms, and one or two hydrogen atoms in R 7 are optionally substituted with a fluorine atom; X 1 , X 2 , X 3 , X 4 and X 6 each independently represent any of a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, and an amide group; X 5 represents any of a single bond, an ether group, and an ester group; X 7 represents any of a single bond, an arylene group having 6 to 12 carbon atoms, a —C(═O)—O—R 18 — group, and a —C(═O)—NH—R 18 — group, and X 7 optionally has one or more selected from an ether group, a carbonyl group, an ester group, and an amide group; R 18 represents a single bond, a linear, branched, or cyclic alkylene group having 1 to 12 carbon atoms, or a divalent aromatic hydrocarbon group having 6 to 10 carbon atoms, and the aromatic hydrocarbon group is optionally partially hydrogenated; Y represents an oxygen atom or a —NR 19 — group, and Y and R 4 are optionally bonded to each other to form a ring; R 19 represents a hydrogen atom, or a linear or branched alkyl group having 1 to 4 carbon atoms; “m” represents an integer of 1 to 4; a1, a2, a3, a4, a5, a6 and a7 represent numbers satisfying 0≤a1≤1.0, 0≤a2≤1.0, 0≤a3≤1.0, 0≤a4≤1.0, 0≤a5≤1.0, 0≤a6≤1.0, 0≤a7≤1.0, and 0<a1+a2+a3+a4+a5+a6+a7≤1.0; and M + represents an ion selected from an ammonium ion, a sodium ion, a potassium ion, and a silver ion.

3. The bio-electrode composition according to claim 1 , wherein the the ion is an ammonium ion shown by the following general formula (3),

wherein R 101d , R 101e , R 101f , and R 101g each represent a hydrogen atom, a linear, branched, or cyclic alkyl group having 1 to 12 carbon atoms, a linear, branched, or cyclic alkenyl group or alkynyl group having 2 to 12 carbon atoms, or an aromatic group having 4 to 20 carbon atoms, and optionally have one or more selected from an ether group, a carbonyl group, an ester group, a hydroxy group, an amino group, a nitro group, a sulfonyl group, a sulfinyl group, a halogen atom, and a sulfur atom; R 101d and R 101e , or R 101d , R 101e , and R 101f , are optionally bonded to each other together with a nitrogen atom bonded therewith to form a ring in which R 101d and R 101e , or R 101d , R 101e , and R 101f , represent an alkylene group having 3 to 10 carbon atoms, or to form a heteroaromatic ring having the nitrogen atom in the formula within the ring.

4. The bio-electrode composition according to claim 2 , wherein the the ion is an ammonium ion shown by the following general formula (3),

wherein R 101d , R 101e , R 101f , and R 101g each represent a hydrogen atom, a linear, branched, or cyclic alkyl group having 1 to 12 carbon atoms, a linear, branched, or cyclic alkenyl group or alkynyl group having 2 to 12 carbon atoms, or an aromatic group having 4 to 20 carbon atoms, and optionally have one or more selected from an ether group, a carbonyl group, an ester group, a hydroxy group, an amino group, a nitro group, a sulfonyl group, a sulfinyl group, a halogen atom, and a sulfur atom; R 101d and R 101e , or R 101d , R 101e , and R 101f , are optionally bonded to each other together with a nitrogen atom bonded therewith to form a ring in which R 101d and R 101e , or R 101d , R 101e , and R 101f , represent an alkylene group having 3 to 10 carbon atoms, or to form a heteroaromatic ring having the nitrogen atom in the formula within the ring.

5. The bio-electrode composition according to claim 1 , comprising, in addition to the components (A) and (B), a component (C) containing:
a silicone resin having an SiO 2 unit and an R x SiO (4-x)/2 unit, wherein R represents a substituted or unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms, and “x” is a number in a range of 2.5 to 3.5;
diorganosiloxane having an alkenyl group; and
organohydrogenpolysiloxane having an SiH group.

6. The bio-electrode composition according to claim 1 , further comprising an organic solvent.

7. The bio-electrode composition according to claim 1 , wherein the component (B) is a powder of lithium titanate having a spinel structure.

8. The bio-electrode composition according to claim 1 , comprising a carbon material in addition to the component (B).

9. The bio-electrode composition according to claim 8 , wherein the carbon material is either or both of carbon black and carbon nanotube.

10. A bio-electrode comprising an electro-conductive base material and a living body contact layer formed on the electro-conductive base material,
wherein the living body contact layer is a cured material of the bio-electrode composition according to claim 1 .

11. The bio-electrode according to claim 10 , wherein the electro-conductive base material comprises one or more species selected from the group consisting of gold, silver, silver chloride, platinum, aluminum, magnesium, tin, tungsten, iron, copper, nickel, stainless steel, chromium, titanium, and carbon.

12. A method for manufacturing a bio-electrode having an electro-conductive base material and a living body contact layer formed on the electro-conductive base material, comprising:
applying the bio-electrode composition according to claim 1 onto the electro-conductive base material; and
curing the bio-electrode composition to form the living body contact layer.

13. The method for manufacturing a bio-electrode according to claim 12 , wherein the electro-conductive base material comprises one or more species selected from the group consisting of gold, silver, silver

Assignees

• Shinetsu Chemical Co

Inventors

• Hatakeyama Jun
• Iwabuchi Motoaki

Classifications

• B01J41/13

  obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds · CPC title

• C08F220/325

  containing glycidyl radical, e.g. glycidyl (meth)acrylate · CPC title

• A61B5/02444 Primary

  Details of sensor (A61B5/02427 takes precedence) · CPC title

• A61B2562/125

  characterised by the manufacture of electrodes · CPC title

• C08L83/04

  Polysiloxanes · CPC title